Section one: Contracting authority
one.1) Name and addresses
NHS Surrey Heartlands Integrated Care Board
Surrey Heartlands Block C, 1st Floor, Dukes Court, Duke Street
Woking
GU21 5BH
nhscs.corporateservices@nhs.net
Telephone
+44 1306646822
Country
United Kingdom
Region code
UKJ26 - East Surrey
Internet address(es)
Main address
https://www.surreyheartlands.org/nhs-surrey-heartlands-board
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Covid-19 nMAB Infusion Service at Home
Reference number
NMAB001
two.1.2) Main CPV code
- 85141200 - Services provided by nurses
two.1.3) Type of contract
Services
two.1.4) Short description
This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands or Frimley in line with NICE TA878.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £408,000
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKJ26 - East Surrey
Main site or place of performance
Homes of patients registered with a GP in:
Surrey Heartlands ICB - East Surrey, Guildford & Waverley, Surrey Downs
Frimley ICB
two.2.4) Description of the procurement
This notice is an intention to award a contract under the PSR, having followed a competitive process. The contract is for the value of £408,000 over three years.
This is a new service provider following notice having been given by a prior supplier for an existing service. During the interim period IV administration has needed to be delivered at a specialist centre in the absence of an infusion service at home.
The service will commence on 1st October 2024; the contract will expire on 30th September 2027.
This contract is for the provision of a nurse led homecare service to administer intravenous COVID-19 neutralising monoclonal antibodies to eligible community patients registered with a GP in Surrey Heartlands ICB except North West Surrey Place which has alternate provision and Frimley ICB in line with NICE TA878.
Patients will have been clinically assessed by East Berkshire Primary Care Trust (EBPCT) and where necessary prescribed IV therapy due to their individual patient circumstances.
The IV therapy is dispensed and delivered by a named community pharmacy in Surrey Heartlands or Frimley which will refer patients onto the home care IV administration service.
EBPCT is also responsible for clinically assessing patients who may be geographically located in the Surrey Heartlands and Frimley areas (except North West Surrey in Surrey Heartlands), explicitly patients in detained estate or Mental Health wards and patients who are holiday in the area.
The aim of the service is to ensure patients within the ICS' can access the provision of homecare IV fairly and equitably and that all patients referred into the service receive IV therapy with 5 days of symptom onset. Some patients may receive therapy on day 6 or 7 with the agreement of the prescribing trust.
two.2.5) Award criteria
Price
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2024/S 000-021381
Section five. Award of contract
A contract/lot is awarded: Yes
five.2) Award of contract
five.2.1) Date of conclusion of the contract
9 August 2024
five.2.2) Information about tenders
Number of tenders received: 3
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor
Ashfield Healthcare Limited
Ground Floor, Ceva House Excelsior Road, Ashby Business Park, Nottingham Road
Ashby‐De‐La‐Zouch
LE65 1NG
Country
United Kingdom
NUTS code
- UKJ26 - East Surrey
National registration number
03286306
The contractor is an SME
No
five.2.4) Information on value of contract/lot (excluding VAT)
Total value of the contract/lot: £408,000
Section six. Complementary information
six.3) Additional information
This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the relevant authority by midnight on 3rd September 2024. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR.
Written representations should be sent to syheartlandsicb.contractsadmin@nhs.net.
Award Decision makers: Evaluation Panel, Surrey Heartlands Commissioning, Contracting and Commercial Committee - Meetings in May and July 2024, Executive Director of Recovery and Sustainability
No Conflicts of Interest were declared for this competitive process.
The PSR Key Criteria were allocated in the following weightings:
Key Criteria 1: Quality & Innovation 25%
Key Criteria 2: Value 26%
Key Criteria 3: Integration, Collaboration and Service Sustainability 24%
Key Criteria 4: Improving access, reducing health inequalities, and facilitating choice 15%
Key Criteria 5: Social Value 10%
Key criteria 1-3 were of effective equal weighting due to an emphasis on the need for assurance regards service model quality, delivery, sustainability, and cost implications inherent therein. Additionally, it was important to gain confidence in a bidder’s ability to mobilise the service efficiently demonstrating collaboration and team working during this time and for future service delivery. The Authority sought a most economically advantageous response. The number of technical evaluation questions posed for each Key Criteria 1-3 differed as the breadth of information altered hence the small percentage differences. Key Criteria 4 and 5 were allocated a reduced weighting because some elements of Key Criteria 4 are outside of the control of the provider due to its referral receipt status. Key criteria 5 was allocated the minimum weighting but this was still considered adequate for bidders to demonstrate their credentials in this arena with a weighting influential enough to impact their status in the procurement process. The winning bidder achieved the highest scores in relation to Key Criteria 2, 4 and 5.
six.4) Procedures for review
six.4.1) Review body
Independent Patient Choice and Procurement Panel
London
Country
United Kingdom